We are live on ! Find out more
ICCM icon

IceCure Medical

14 hedge funds and large institutions have $268K invested in IceCure Medical in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital invested

Capital invested by funds: $120K → $268K (+$147K)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

17% more funds holding

Funds holding: 1214 (+2)

0.02% more ownership

Funds ownership: 0.01%0.03% (+0.02%)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ICCM Hedge Fund Activity: Q2 2024 in Review

14 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q2 2024, worth a combined $268K — up 123% from $120K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ICCM positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $180K. The largest seller was HRT Financial, exiting entirely with an estimated $22K sold.

  • 14 institutional investors held IceCure Medical (ICCM) as of Q2 2024, up from 12 in Q1 2024.
  • Funds reported $268K of IceCure Medical stock for Q2 2024, up 123% quarter-over-quarter.
  • 5 funds opened new IceCure Medical positions in Q2 2024 and 3 closed out, a net change of +2 holders.
  • The largest IceCure Medical buyer in Q2 2024 was Citadel Advisors, an estimated $180K added.
  • The largest IceCure Medical seller in Q2 2024 was HRT Financial, an estimated $22K sold.

Based on aggregated 13F filings for Q2 2024.